International Journal of Clinical Pharmacy

Papers
(The H4-Index of International Journal of Clinical Pharmacy is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
ESCP International Workshop: Pharmacotherapy challenges in the developing years: from conception to adolescence 24–25 April 2024, Bratislava, Slovakia63
Bacillus coagulans TBC169 probiotics for intestinal function recovery after gynecological open surgery: a randomized, double-blind, placebo-controlled trial59
Comment on: “whether temporal discounting is domain‑specific between health outcomes and money—a systematic review and meta‑analysis”50
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study37
Implementation status of safety measures to prevent errors with non-oncologic methotrexate: surveys in community and hospital pharmacies37
A systematic review of quantitative studies exploring staff views on antipsychotic use in residents with dementia in care homes33
Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer31
Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study27
Non-cardiovascular medication and readmission for heart failure: an observational cohort study27
Characterising pharmacists’ interventions in chronic non-cancer pain care: a scoping review27
Parents’ perspectives towards paediatric confectionary masked medications: a qualitative study27
Efficacy and safety of metformin compared to insulin in gestational diabetes: a systematic review and meta-analysis of Chinese randomized controlled trials26
Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data26
Response to comment on 'Perioperative esketamine combined with butorphanol versus butorphanol alone for pain management following video-assisted lobectomy: a randomized controlled trial'24
Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units23
Clinical pharmacist consultant in primary care settings in Slovenia focused on elderly patients on polypharmacy: successful national program from development to reimbursement23
A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country23
Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children23
Attitudes of non-participating general practitioners and community pharmacists towards interprofessional medication management in primary care: an interview study22
Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–202022
Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis21
Medication regimen complexity index and rehabilitation outcomes in post-acute hip fracture patients study: a retrospective study21
Impact of intra-patient variability of tacrolimus on allograft function and CD4 + /CD8 + ratio in kidney transplant recipients: a retrospective single-center study21
0.15097117424011